Aura Minerals is looking to raise $210 million through a public offer on Nasdaq
Canada-based mining company Aura Minerals has announced the launch of a public offering of US common stock in accordance with the Form F-1 registration statement filed with the US Securities and Exchange Commission (SEC).
The company aims to raise approximately $210 million based on its latest stock prices and exchange rates.
The stock will be listed in the Nasdaq Global Select Market under the symbol “Augo.”
This offering is exclusive to the US only through a prospectus, as Bofa Securities and Goldman Sachs & Co serves as global coordinators.
Other financial institutions, including BTG Pactual and ItaúBBA, are co-book runners and involve additional co-managers. A copy of the preliminary prospectus is available on request from BOFA Securities.
Aura Minerals has submitted the necessary documents to the SEC for upcoming sale, but is still waiting for approval. Until then, the company will not engage in the sale of securities or commit to purchasing them.
The Aura recruitment excludes shareholders’ preemptive rights and follows the company’s memorandum and association article. This applies to Brazilian deposit receipt holders as well.
This offer does not constitute a Brazilian offer and complies with local securities laws and regulations.
Furthermore, this offer is not registered with Brazilian CVM.
Common stock should not be offered or sold within Brazil except under certain conditions that do not qualify for public offerings or distribution in accordance with the rules and regulations governing Brazilian securities.
Furthermore, aura minerals We have entered a definitive arrangement agreement Last October, I acquired Bluestone Resources.
The $74.3 million acquisition includes the Cerro Blanco Gold project and the MITA geothermal project.
“Aura Minerals is looking to raise $210 million through a public offer at Nasdaq,” was originally created and published. Mining Technologya brand owned by GlobalData.
The information on this site is contained in good faith for general information purposes only. It is not intended to be the advice you should resort to, and we will not give any representations, warranties or warranties, whether express or implied regarding its accuracy or completeness. You should seek expert or expert advice before taking or refraining from taking any medication based on the content on our site.